Aspirin Exacerbated Respiratory Disease Market Trends

  • Report ID: 4139
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Aspirin Exacerbated Respiratory Disease Market Trends

Growth Drivers  

  • Rising Cases of Asthma across the Globe
  • Growing Government Initiatives  

Challenges 

  • Lack of Awareness Amongst People

Aspirin Exacerbated Respiratory Disease Market: Key Insights

Healthcare Expenditure per Capita, (USD), 2015-2018

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Base Year

2024

Forecast Year

2025-2037

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4139
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The aspirin exacerbated respiratory disease industry size is poised to grow at substantial growth rate during the forecast period i.e., between 2025-2037.

Surging cases of asthma will impel the market growth.

North America industry is poised to dominate majority revenue share by 2037, propelled by presence of a plethora of pharmaceutical companies.

The major players in the market are Pfizer Inc., Teva Pharmaceuticals Industries Ltd., and Cadila Healthcare Ltd. (CHL).
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample